Cargando…

Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation

Sensitized patients received desensitization therapy with rituximab for kidney transplantation. However, the impact of rituximab dose on hepatitis B virus (HBV) reactivation is unknown. Patients who underwent living donor kidney transplantation between 2008 and 2016 were grouped according to rituxim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Juhan, Park, Jun Yong, Kim, Deok Gie, Lee, Jee Youn, Kim, Beom Seok, Kim, Myoung Soo, Il Kim, Soon, Kim, Yu Seun, Huh, Kyu Ha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199240/ https://www.ncbi.nlm.nih.gov/pubmed/30353021 http://dx.doi.org/10.1038/s41598-018-34111-5

Ejemplares similares

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk
por: Kim, Eun Jin, et al.
Publicado: (2021)

The recovery status from delayed graft function can predict long-term outcome after deceased donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2017)

Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group
por: Song, Young Hae, et al.
Publicado: (2012)

Role of Plasma Exchange in ABO-incompatible Kidney Transplantation
por: Yoo, Soohun, et al.
Publicado: (2012)

Risk Due to ABO Incompatibility and Donor-Recipient Weight Mismatch in Living Donor Kidney Transplantation: A National Cohort Study
por: Lee, Jun Young, et al.
Publicado: (2021)

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
por: Lee, Juhan, et al.
Publicado: (2015)

Comparison of high-dose IVIG and rituximab versus rituximab as a preemptive therapy for de novo donor-specific antibodies in kidney transplant patients
por: Kim, Hyung Woo, et al.
Publicado: (2023)

Clinical impact of serum bilirubin levels on kidney transplant outcomes
por: Lee, Juhan, et al.
Publicado: (2021)

Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells
por: Kim, Eun Jee, et al.
Publicado: (2021)

Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies
por: Kim, Deok Gie, et al.
Publicado: (2018)

The feasibility of organ transplantation during the COVID-19 outbreak: experiences from South Korea
por: Lee, Juhan, et al.
Publicado: (2020)

Long-term compensation of renal function after donor nephrectomy
por: Lee, Yong Pyo, et al.
Publicado: (2020)

Association between post-transplant serum uric acid levels and kidney transplantation outcomes
por: Kim, Deok Gie, et al.
Publicado: (2018)

Effect of rituximab dose on induction therapy in ABO-incompatible living kidney transplantation: A network meta-analysis
por: Lee, Hee Ryong, et al.
Publicado: (2021)

Graft-versus-host disease after simultaneous pancreas-kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2020)

Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Lee, Su Hwan, et al.
Publicado: (2017)

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
por: Lee, Juhan, et al.
Publicado: (2015)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Survival Benefit of Kidney Transplantation in Patients With End-Stage Kidney Disease and Prior Acute Myocardial Infarction
por: Kim, Deok-Gie, et al.
Publicado: (2023)

Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors
por: Kim, Jieun, et al.
Publicado: (2017)

Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report
por: Lee, Juhan, et al.
Publicado: (2017)

The Immunomodulating Effects of Thalidomide and Dexamethasone in a Murine Cardiac Allograft Transplantation Model
por: Kim, Soo Jin, et al.
Publicado: (2022)

2079. The Relation Between Panel Reactive Antibody Assay and Cytomegalovirus Reactivation in Seropositive Solid Organ Transplantation Recipients
por: Kwon, Da Eun, et al.
Publicado: (2018)

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
por: Oh, Jongwook, et al.
Publicado: (2020)

Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study
por: Choi, Hoon Young, et al.
Publicado: (2016)

Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report
por: Song, Seung Hwan, et al.
Publicado: (2016)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2023)

Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
por: Park, Borae Geum, et al.
Publicado: (2019)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study
por: Lee, Juhan, et al.
Publicado: (2019)

ABO-incompatible liver transplantation using only rituximab for patients with low anti-ABO antibody titer
por: Lee, Boram, et al.
Publicado: (2019)

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
por: Go, Se‐Il, et al.
Publicado: (2016)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA
por: Chung, Byung Ha, et al.
Publicado: (2015)

The impact of pretransplant 25-hydroxy vitamin D deficiency on subsequent graft function: An observational study
por: Kim, Hyunwook, et al.
Publicado: (2012)

Clinical Characteristics and Treatment Outcomes of Colorectal Cancer in Renal Transplant Recipients in Korea
por: Kim, Jeong Yeon, et al.
Publicado: (2011)

Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts
por: Hwang, Jeong Kye, et al.
Publicado: (2011)

Complications and outcomes following inguinal lymphadenectomy for malignant melanoma in an Asian population
por: Lee, A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ekktl03655sop626onlogcv62v